Oksana Karnabeda - Bogomolets National Medical University

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 21 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Genetic Profiling in Chronic Lymphocytic Leukemia: the Role of TP53 Mutations and IGHV Status in Treatment Decision-Making – A Case Report

Kateryna Khurdepa,Oksana Karnabeda

Galician Medical Journal (2024)

引用0浏览0引用

PB1753: EVALUATION OF IMMUNOPHENOTYPIC CHARACTERISTICS OF RESIDUAL CELLS IN COMPARISON WITH NORMAL HEMATOGONES AND MATURE CELLS IN CHILDREN WITH B-CELL LYMPHOBLASTIC LEUKEMIA

Oksana Karnabeda,Kateryna Vilchevska, Iryna Bakhchivandzhi

HemaSphereno. S3 (2023): e02217c7-e02217c7

引用0浏览0引用

A Prospective Ukrainian Multicentre Cohort Study of Pet Value Prognostic Role in Primary Patients with Hodgkin Lymphoma (HL): Six-Year a Brief Review

Olga Novosad,Iryna Kryachok,Olexandr Gorbach,Tymur Rudiuk,Ian Pastushenko,Yaroslav Kmetyuk,Olga Karpova,Larisa Mykhalska,Viktor Kozlov,Mykola Novikov,Olena Oliinichenko, Viktoriya Stratienko,Oksana Karnabeda, Andrey Ashykhmin,Tatyana Kadnikova, Natalia Shudrak

Bloodno. Supplement 1 (2023): 6207-6207

引用0浏览0引用

Unmet Needs in the Treatment of Chronic Lymphocytic Leukemia and Prospects for Patients in the Republic of Moldova

Igori Vinogradov, Tetiana Perekhrestenko,Oksana Karnabeda, Inna Satcovscaia,Sanda Buruiana

The Moldovan Medical Journalno. 1 (2023): 77-82

引用0浏览0引用

P590: MODIFICATIONS IN PRIMARY HEMOSTASIS AS ADDITIONAL RISK FACTORS OF BLEEDING IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML): UKRAINIAN PROSPECTIVE STUDY IN A REAL-LIFE COHORT

Zinaida Stupakova,Iryna Dyagil,Zoya Martina,Anna Sergeieva,Oksana Karnabeda,Ulyana Melnyk,Olga Novosad,S. R. Rushkovsky

HemaSphereno. S3 (2023): e1795585-e1795585

引用0浏览0引用

OMS906, a Novel Alternative Pathway MASP-3 Inhibitor, Normalizes Hemoglobin Levels and Increases Clone Size in Treatment-Naïve PNH Patients

Oksana Karnabeda,Valentyn Moskalenko, Zoreslava Lysak,Narinder Nangia, Charlotte A. Osborne,J. Steve Whitaker,Eleni Gavriilaki, Jens Panse

Bloodno. Supplement 1 (2023): 573-573

引用0浏览0引用

Additional Risk Factors of Severe Bleeding in Patients With Newly Diagnosed Acute Myeloid Leukemia (AML): Ukrainian Prospective Study in a Real-Life Cohort

Zinaida Stupakova,Iryna Dyagil,Zoya Martina,Anna Sergeieva,Oksana Karnabeda,Ulyana Melnyk,Olga Novosad,Stanislav Rushkovsky

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2023): S298-S298

引用0浏览0引用

Primary hemostasis dysfunctions and bleeding risk in newly diagnosed acute myeloid leukemia

Zinaida Stupakova, Iryna Diagil,Ulyana Melnyk,Oksana Karnabeda,Anna Sergeieva

Journal of cancer research and clinical oncology（2023）

引用0浏览0WOS引用

Pb2114: treatment results in patients with diffuse large b-cell lymphoma from high-risk group

K. Filonenko,I. Kriachok,A. Martynchyk,I. Titorenko,Y. Stepanishyna,O. Aleksyk, K. Ukianchenko,I. Pastushenko, Y. Kushchevyy,O. Novosad,O. Karnabeda, I. Diagil,V. Kozlov

HemaSphere (2022): 1985-1986

引用0浏览0引用

PB1846: ALTERATIONS IN PRIMARY HEMOSTASIS AS ADDITIONAL RISK FACTORS OF BLEEDING IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML): UPDATED PROSPECTIVE ANALYSIS

Z. Stupakova, D. Iryna, M. Zoya, S. Anna,O. Karnabeda,U. Melnyk,O. Novosad

HemaSphere (2022): 1726-1727

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn